Refine by
Medical Endoscopy Articles & Analysis
18 news found
(NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced the winners of its 2017 weight loss contest, which recognizes patients for their successful weight loss with the ReShape Balloon™. ...
Initial results show the duodenal jejunal bypass liner (DJBL) technology met overall glycemic control efficacy and SAE related device removal safety endpoints Findings Presented at DDW 2022 BOSTON – June 15, 2022 – GI Dynamics, a medical device company that is developing the EndoBarrier® System for patients diagnosed with type 2 diabetes and obesity, announced ...
” Maria Sainz, Former President and CEO of AEGEA Medical Inc., a women’s health technology company acquired by CooperSurgical in 2021. She serves as a member of the Board of Directors of ShockWave Medical, Inc., Avanos Medical, Inc., and Atrion Corporation. Ms. Sainz brings more than 20 years of experience leading large ...
Scivita Medical's product covers both flexible endoscopy and rigid endoscopy, and has unique advantages in the research and commercialization of all cutting-edge technologies in the field of medical endoscopes. ...
Eli Lilly and Company (NYSE: LLY) announced today that mirikizumab met the primary and all key secondary endpoints in LUCENT-1, a 12-week Phase 3 induction study evaluating the efficacy and safety of mirikizumab for the treatment of patients with moderate to severe ulcerative colitis (UC). LUCENT-2, a multicenter, randomized, double-blind, placebo-controlled maintenance study of mirikizumab in ...
BOSTON — November 5, 2020 — GI Dynamics® Inc. (“GI Dynamics” or the “Company”), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, has appointed Joseph Virgilio as president and chief executive officer of GI Dynamics, Mark Lerdal as chairman of the Board of Directors (“the Board”) and ...
On October 18. 2020. the online meeting of "Scivita Medical Navigates Medical Innovation' Scivita 4K Medical Ultra-high-definition Laparoscopy in Pediatric Surgery Seminar sponsored by Pediatric Surgery Branch of Guangdong Medical Association and undertook by Guangzhou Women and Children' s Medical Center ...
With the acquisition in 1996 of Schott Fiber Optics’ flexible endoscope division, medical and industrial endoscopes were added to the product portfolio. ...
MedTech Innovator, the largest accelerator of medical devices in the world, today announced the finalists for MedTech Innovator’s eighth annual competition: Cellvie, Circadia Health, Lief Therapeutics, Moray Medical, and Rhaeos. ...
BOSTON — September 10, 2020 — GI Dynamics® Inc. (‘GI Dynamics” or the “Company”), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce the initial closing of its private placement offering of Series A Preferred Stock led by Crystal Amber Fund Limited (“Crystal Amber”), ...
BOSTON and SYDNEY — 15 July 2020 — GI Dynamics® Inc. (ASX:GID) (the “Company”), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, provides the following update regarding the removal of the Company from the Official List of the Australian Securities Exchange (“ASX”) (“Official List”). ...
BOSTON and SYDNEY — 15 July 2020 — GI Dynamics® Inc. (ASX:GID) (the “Company”), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, advises that it has received a notice of conversion from Crystal Amber Fund Limited (“Crystal Amber”) (a Related Party for Australian Securities Exchange ...
BOSTON and SYDNEY — 1 July 2020 — GI Dynamics® Inc. (ASX:GID) (”the “Company”), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, provides the following update regarding the extension of the maturity date of the Senior Secured Convertible Promissory Note issued to Crystal Amber Fund Limited (“Crystal ...
BOSTON and SYDNEY — 22 June 2020 — GI Dynamics® Inc. (ASX:GID) (“GID” or the “Company”), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, announces that it held its Special Meeting of Stockholders on 21 June 2020 and, in accordance with ASX Listing Rule 3.13.2, is pleased to confirm that each of the ...
BOSTON and SYDNEY — 19 June 2020 — GI Dynamics® Inc. (ASX:GID) (“GID” or the “Company”), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce that it has issued a US$750,000 Unsecured Convertible Promissory Note to Crystal Amber Fund Limited (“Crystal Amber”), the ...
A STUDY EVALUATING ENDOSCOPIC PROCEDURE TIME REMOVING COMPLEX COLORECTAL POLYPS SHOWS SUPERIORITY OF LUMENDI’S DILUMEN DEVICE OVER A CONTROL GROUP. Connecticut-based medical device innovator Lumendi LLC reports that its 1:1 randomized trial of the DiLumen Endolumenal Interventional Platform (EIP) successfully met the primary endpoint of an IRB-approved 200-patient ...
A STUDY EVALUATING ENDOSCOPIC PROCEDURE TIME REMOVING COMPLEX COLORECTAL POLYPS SHOWS SUPERIORITY OF DILUMEN OVER CONTROL GROUP. Connecticut-based medical device innovator Lumendi, LLC reports that its 1:1 randomized trial of the DiLumen Endoluminal Interventional Platform (EIP) successfully met the primary endpoint of an IRB-approved 200-patient prospective study. ...
In a continuing effort to promote molecular imaging, the international Photonics Translational Research - Medical Photonics (MEDPHOT) consortium, led by professor of Biophotonics Johannes de Boer of Vrije Universiteit Amsterdam has been awarded a 5.4 million euro grant from the NWO for the program “Light for a better view on ...